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charts. Results: Patients were classiﬁed into one of three categories, based on
their SGA score (A) Well-nourished; (B) Mild- Moderate Malnutrition,
(C) Severe malnutrition. Malnutrition (B or C) was detected in 10% of PD
patients, compared to the 2008/09 audit where 76% of MPD patients had some
degree of malnutrition. Summary: These results were much lower than
malnutrition rates (76%) in the MPD patients audited in 2008/09. A number of
factors affecting the PD service after the 2008/09 audit could explain the
decrease in malnutrition rates including the implementation of free oral
nutrition supplements to MPD patients, development of service wide culturally
appropriate education resources used in the pre-dialysis and dialysis stage.
Future research into the correlation between improved peritonitis rates and
decreased malnutrition rates in the population are warranted.
http://dx.doi.org/10.1016/j.krcp.2012.04.401
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Protein-energy wasting (PEW) is crucial complication in prevalent
hemodialysis (HD) patients. Abnormality of biomarkers such as IL-6, NT-pro-
BNP, and adiponectin (ADPN) contribute to PEW. However, associations of the
biomarkers with PEW according to BMI levels have not been fully evaluated.
Thus those associations were assessed by a cross-sectional cohort study of
prevalent HD patients (n¼386). PEW was deﬁned by subjective global
assessment (n¼108). IL-6 levels were inversely, and NT-pro-BNP and ADPN
levels were positively correlated with BMI levels. Odds ratio (OR) of log IL-6 (OR
1.5, CI 1.0, 2.2), log NT-pro-BNP (OR 1.7, CI 1.3, 2.2), and log ADPN (OR 1.9, CI
1.1, 3.2) to PEW were signiﬁcantly increased in logistic multivariate regression
model. ORs of log NT-pro-BNP and log ADPN for PEW were progressively
increased in patients with threshold 21 kg/m2oBMI, but progressively
decreased in those below this threshold. On the other hand, OR of log IL-6 for
PEW was progressively decreased in patients with threshold 21 kg/m2oBMI,
but similar in those below this threshold. These associations were conﬁrmed by
the models adjusted with confounder. In conclusions, predictive values of IL-6,
NT-pro-BNP and ADPN for PEW state may be dependent on BMI levels in
prevalent HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.402
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The aim of this study was to investigate the incidence and clinical
features of EPS in PD patients from a single university center in Korea. The
data were retrospectively collected from 606 prevalent PD patients
between August 2001 and August 2011. The diagnosis of EPS was based on
clinical signs and symptoms, mostly conﬁrmed by radiological ﬁndings.
Eight patients (incidence rate of 1.3%) were diagnosed with EPS. They
had at least one of three symptoms: abdominal pain, vomiting, or
abdominal distension. Mean age of the patients (4 males and 4 females)
was 48.5 (range: 33 to 65) years. Mean duration of PD was 111.8 (range: 23
to 186) months. The causes of ESRD were chronic glomerulonephritis
(n¼6), followed by hypertensive nephrosclerosis (n¼1) and diabetic
nephropathy (n¼1). All the patients except one had 3 or more episodes of
peritonitis. Seven patients were diagnosed with EPS after stopping PD and
only one stayed on PD after initial diagnosis and treatment. The use of
icodextrin or beta-blockers and angiotensin-converting enzyme inhibitors
or angiotensin II receptor blockers was not different in the patients without
EPS. Total parenteral nutrition was used in all patients. Three patients were
treated with corticosteroids (0.51 mg/kg/day) in addition to tamoxifen
(10–20 mg daily) and four with only total parenteral nutrition. Only one
patient received corticosteroids (1 mg/kg/day) combined with elective
surgical intervention, adhesiolysis. Of the 8 patients diagnosed with EPS,
4 died with an overall mortality rate of 50%.
In this retrospective analysis, we conﬁrmed that EPS is rare but a serious
life threatening complication in patients on long-term PD. To reduce the
incidence and mortality of EPS, careful monitoring and early diagnosis may
be needed.
http://dx.doi.org/10.1016/j.krcp.2012.04.403
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Nutrition is one of the important issues and edema will overestimate the
real body weight among dialysis patients. Lean body mass might reﬂect the
real nutrition status. Creatinine is the product of muscle metabolism,
creatinine generation can reﬂect the lean body mass (LBM). In peritoneal
dialysis (PD) patients, creatinine generation could be evaluated by routine
clearance measurement. This study will investigate the relationship among
LBM, patient survival and PD technique therapy. Between 2002 and 2003, a
total 115 patients who underwent PD for more than 3 months were
enrolled in this study. Follow up ended in Dec. 2011. These patients were
categorized into two groups according the median value of lean body mass
to body weight (LBM/BW %) evaluated at ﬁrst month. Age, sex, serum
creatinine, albumin, and normalized protein catabolic rate (nPCR) were the
independent determinants for LBM/BW%. The patient survival (68 vs 94
months ) and technique survival (55 vs 65 months) were longer in the
higher LBM/BW%. Besides, peritonitis incidence, hospitalization episodes
and hospitalization stay duration were lower in the higher LBM/BW%
groups. The LBM/BW% is also the independent determinant for technique
and patient survival after adjustment of age, diabetes, sex.
In conclusion, initial LBM/BM% can predict PD patients and technique
survival. Since the LBM/BW% is easily obtained in the routine PD clearance
measurement and can reﬂect the real nutrition status, this parameter could
be used extendedly to predict PD outcomes.
http://dx.doi.org/10.1016/j.krcp.2012.04.404
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Missed dialysis sessions can have a cascading effect on patient clinical
outcomes. In addition to missing the dialysis itself, patients fail to receive
medications—such as ESAs—that are dosed at each session. This analysis
assessed ESA dose changes following missed session episodes in order to
evaluate ‘‘catch-up dosing.’’
In a retrospective analysis, we assessed missed session and epoetin alfa
(EPO) utilization data in 2010 from adult (Z 18 yrs old), hemodialysis (HD)
patients. Consecutive misses were considered part of a missed session
‘‘episode.’’ All misses were included (even if patient was hospitalized).
Differences in EPO utilization in the periods 14 days, 30 days and 31-60
days before and after missed session episodes were calculated and
stratiﬁed by length of episode, and whether additional sessions were
missed in the before/after periods. Total monthly EPO dose was also
calculated and stratiﬁed by number of missed sessions.
Kidney Res Clin Pract 31 (2012) A16–A96A36
Patients used signiﬁcantly more EPO after a missed session episode, and
differences in per session EPO dose were generally greater the longer the
episode. For missed session episodes with no additional misses in the 30
day before/after period, increases of 18% to 30% per session were seen,
depending on episode length. For longer episodes, usually due to
hospitalization, differences were sustained over 60 days. Analyses which
included additional missed sessions in the before/after period showed
similar patterns. Beyond these per-session associations, the total amount of
EPO used in a month increased with number of missed sessions (through
up to 5 missed sessions), even though these patients (by deﬁnition) were
not receiving as many administrations of EPO.
Missed session episodes result in signiﬁcant increases in ESA utilization
in the post-miss period, and also in total monthly ESA use. Such increases
should be considered in any assessment of impact of missed sessions: both
clinical and economic.
http://dx.doi.org/10.1016/j.krcp.2012.04.405
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Hemodialysis (HD) patients are frequently hospitalized. Interruption of
normal dialysis and 3x/weekly ESA treatments, along with the cause of
hospitalization, normally leads to declines in Hb and increased ESA
utilization post-hospitalization.
In this retrospective analysis, we examined Hb levels and ESA use before
and after hospitalization in adult (Z18 yrs old) HD patients from 1/1/
2009-12/31/2010. Hospitalizations preceded by 4 30 hospital-free days
were included in the analysis.
Pre and post-hospitalization Hb test data was available for 156,353
events: 67.4% showed a drop in Hb levels in the 30 days after
hospitalization, 0.7% had no change and 32.7% exhibited a rise in Hb levels.
For patients with falling Hb, the mean level after hospitalization was
10.55 g/dL, compared to 11.87 g/dL before hospitalization, corresponding
to a mean drop of 1.32 g/dL (SD¼1.00). Mean monthly Hb levels for all
patients were 11.48 g/dL and 10.88 g/dL before and after hospitalization,
respectively.
ESA dose changes were assessed for 179,929 hospitalization events.
Analysis of ESA use over 30 days before/after hospitalization showed
increased epoetin alfa (EPO) use post-hospitalization in 60.8% of events,
4.9% showed no mean change, and 34.3% showed a drop in EPO use. Of the
hospitalizations with mean per-session increases in EPO, in 69.7% of events
the rise in EPO dose occurred before the ﬁrst post-hospitalization Hb test
result was known, and in 30.3% the increase occurred after Hb testing.
We found that hospitalizations frequently lead to a drop in patients’ Hb
levels and an increase in post-hospitalization EPO dose. However, EPO dose
increases often occur before post-hospitalization Hb levels are known.
Strategies for better management of anemia in the post-hospitalization
period should be assessed.
http://dx.doi.org/10.1016/j.krcp.2012.04.406
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Purpuse: It has been postulated that ﬂuid overload and lipid metabolic
derangement is more common in peritoneal dialysis (PD) patients than in
hemodialysis (HD) patients. The purpose of this study was to evaluate the
differences in body composition in HD and PD patients.
Methods: We compared whole body composition using bioimpedence
analysis (BIA) in 14 hemodialysis patients and 14 peritoneal dialysis patients.
BIA was performed at 1, 3, 6, and 12 months after initiation of HD or PD
Results: Compared with HD patients, PD patients had a higher ratio of
extracellular ﬂuid/total body ﬂuid at 12 months (0.39 vs 0.34, po0.05) and a
lower level of serum albumin (3.6 g/dL vs. 3.9 g/dL, po0.05). There were no
differences in skeletal muscle mass, body fat mass, visceral fat area or serum
total cholesterol level between HD and PD patients.
Conclusions: Extracellular ﬂuid overload and hypoalbuminemia were more
common in PD patients than in HD patients. Serial assessment andmonitoring
of nutrition and volume status are needed for early recognition and
management in these patients
http://dx.doi.org/10.1016/j.krcp.2012.04.407
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It is possible to observe improvement in the general state of patients
receiving maintenance hemodialysis, including decreased joint symptoms,
decreased pruritus, and better appetite, by using a high-efﬁciency, high-ﬂux
dialysis membrane. We aimed to determine the effects of the use of a high-
ﬂux dialysis membrane on improvement in the nutritional status of dialysis
patients. Twomonths before the replacement with a high-efﬁciency, high-ﬂux
dialysis membrane and one, three, six, and twelve months after the
replacement, the subjective global assessment (SGA), biochemical markers,
and a Body Composition Analyzer was used to assess the nutritional status
and determine hemodialysis adequacy, along with a biochemical test, in 25
stable patients (M: F¼10:15, 54.5712.7 (3780) yrs). Of all the patients,
3 got better results from SGA, 12 the same results, and 10 worse results, in the
follow-up period. There was no signiﬁcant increase or decrease after the
replacement with a high-ﬂux dialysis membrane in biochemical parameters
and nutritional parameters. While there was also no improvement in body
weight, fat mass, muscle mass, lean fat mass, visceral fat, or the degree of
edema measured by the body composition analyzer after the replacement,
basal metabolism was improved from 1179.27143.5 kcal before the
replacement to 1264.87145.4, 12417138.3, and 1201.07317.0 kcal one,
three, twelve months after the replacement, respectively, on the average
(po0.001, p¼0.001, p¼0.023); thus, the improvement was greatest one
month after the replacement and, then, decreased over time. In conclusion,
the use of a high-efﬁciency, high-ﬂux dialysis membrane generally failed to
improve the nutritional status of patients receiving maintenance hemodialysis
but increased the indirect index of basal metabolism alone at its early stage.
http://dx.doi.org/10.1016/j.krcp.2012.04.408
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There are few reports about therapeutic effects of low protein diet on the
progression of chronic renal failure due to autosomal dominant polycystic
kidney disease (ADPKD), although the disease is common.The annual
incidence rate for end-stage renal disease caused by ADPKD is around 6 per
million.In this retrospective study in one center, ten chronic renal failure
patients due to ADPKD with creatinine clearnce of 17.073.3 mL/min /
1.73 m2 and serum creatinine (Cr) level of 4.470.7 mg/dL were studied for
40 months after the introduction of severe low protein diet (SLPD)
(0.4870.03 g/kgBW/day) without supplementation of essential amino
acids or keto-analogues. Dietary protein intake was estimated by urea
appearance rate from 24hr urine sample according to Mitch-Maroni’s
formula. The results clearly showed that n1/Cr/month(103) was
signiﬁcantly suppressed from 5.870.9 to 2.070.6 following the
introduction of SLPD (po0.02). Furthermore, BUN/Cr ratio decreased from
10.470.02 to 7.370.02 (po0.01). Mean blood pressure (mmHg)
remained unchanged; 9273 vs 8973 (ns), and urinary protein excretion
(g/day) did not change; 0.670.2 vs 0.670.1 (ns). There were no signiﬁcant
differences between body mass index, serum albumin, transferrin and
hemoglobin levels as the indices of nutritional state before and after the
introduction of SLPD.In conclusion, SLPD was effective in suppressing the
progression of further decline in renal function due to ADPKD under
nutritionally safety condition in this cohort.
http://dx.doi.org/10.1016/j.krcp.2012.04.409
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